Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
close collaboration and innovation. Together, they drive ecosystem development by combining cutting-edge research with industrial expertise, fostering new technologies, business models, and talent
-
the University of Oulu (Finland) for a fixed term of 3 years About the profilation HYDROGEN FUTURE AS A CLIMATE SOLUTION (H2FUTURE) combines the University of Oulu’s research strengths in future H2 production
-
and Signal Analysis (CMVS) at the Faculty of Information Technology and Electrical Engineering, University of Oulu. CMVS is a creative, open, and internationally attractive research unit, combining the
-
combine cutting-edge wet-lab experimentation with advanced computational approaches to map the diversity, dynamics, and tissue distribution of viruses in the human body. We investigate how these viral
-
mental health and computational social science, using large-scale social media analysis, smartphone-based sensing, and agent-based modeling. Combining macro-level patterns with micro-level behavioral data
-
chemical cocktail by combining state-of-the-art molecular-level simulations on recently discovered aerosol-forming organic compounds, automated reaction mechanism generators, and high-resolution local scale
-
and experimental methods. RESTART project studies the future urban chemical cocktail by combining state-of-the-art molecular-level simulations on recently discovered aerosol-forming organic compounds
-
that transform dynamic environmental processes, such as sedimentation, meltwater flow, and vegetation change, into active drivers of adaptive design. This interdisciplinary work combines advanced computational
-
heterostructures. The involved STM platforms include 1K-STM under an external magnetic field up to 8T and 4K-STM combined with optical spectroscopy which allows you to perform STM-induced luminescence and tip
-
with emphasis on mouse models, tumor models, cell culture and flow cytometry. The researcher (position 2) will participate in a project which investigates novel combination immunotherapies (immune